Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
1 Answers
Mednet Member
Rheumatology · Johns Hopkins School of Medicine
If the patient does not require any treatments for CLL that are potentially immunosuppressive, I would continue TNF-inhibitor therapy in this setting. It is always helpful to discuss the case with the patient's hematologist/oncologist to make sure everyone is comfortable with the plan.